Despite billions invested, real-world evidence (RWE) still struggles to deliver lifecycle impact in Pharma and Medtech. Fragmented data, poor standards, and underuse in early R&D continue to limit ROI. Discover what’s needed to fix the system—and how smarter, connected RWE strategies can drive product success.
Post-market surveillance in pharma and medtech is overdue for transformation. Fragmented systems, manual workflows, and compliance barriers are slowing progress—while AI remains underutilized. Discover why smarter, AI-ready PMS strategies are becoming a competitive necessity.
Pharma and Medtech pour billions into targeted marketing, but HCP engagement keeps dropping. What’s going wrong? 🔍 Read more to uncover the key inefficiencies and smarter strategies for better results.
Pharma and Medtech companies invest billions in professional education, yet HCP engagement remains low. Fragmented industry portals, compliance restrictions, and lack of personalization are limiting impact. Discover the 10 biggest inefficiencies in industry-sponsored professional education—and how a smarter, data-driven approach can improve engagement and ROI.
Patient recruitment inefficiencies delay up to 85% of clinical trials, costing sponsors $600K–$8M per day. With less than 5% of eligible patients enrolling, recruitment remains a major challenge. Explore key insights and data-driven strategies to improve retention and accelerate trial success.